To the Point
First Patient Treated in Stem Cell Study
Last Friday, researchers in Atlanta injected millions of embryonic stem cells into a patient with a damaged spine, in the first clinical trial of embryonic stem cells in a human being. Phase I is for safety, but they're looking for therapeutic consequences as well. Some critics say it's premature, while others contend it's immoral.
By Warren Olney • • 1 min readLast Friday, researchers in Atlanta injected millions of embryonic stem cells into a patient with a damaged spine, in the first clinical trial of embryonic stem cells in a human being. Phase I is for safety, but they're looking for therapeutic consequences as well. Some critics say it's premature, while others contend it's immoral. Rob Stein is national science reporter at the Washington Post.
The full episode
3 of 3
Obama, Dems Keep Pushing Claims on GOP's Secret Donors- 0:00Guantanamo Detainee Ghailani on Trial in NYC Federal Court
- 7:40Big Money and Stealth Campaigns
- 42:36First Patient Treated in Stem Cell StudyYou’re reading this
The full episode
3 of 3Obama, Dems Keep Pushing Claims on GOP's Secret Donors- 0:00Guantanamo Detainee Ghailani on Trial in NYC Federal Court
- 7:40Big Money and Stealth Campaigns
- 42:36First Patient Treated in Stem Cell StudyYou’re reading this